Company Profile
Alpha chimica is established at the school of Pharmacy at the University of Paris-South (Châtenay-Malabry) for the purpose of developing biomimetic catalyst technology, new chemical entities, and drug candidates. We have created human Cytrochrome P450 mimics for producing phase 1 metabolites in high yield. Among the advantages of our approach are rapid turnaround and high yield of prospective metabolites. Our customers gain better understanding and comprehensive evaluation of available pathways of biological oxidation. Alpha chimica’s clientele includes leaders in the pharmaceutical/biotech industry, who rely on our skill and confidentiality.
